
NURIX THERAPEUTICS INC
NRIXNASDAQ๐ #1532 by market capEarnings Oct 7US Equity
$25.96โฒ $0.08 (+0.31%)
๐
Pre-market$26.55โฒ 2.27%Regular close ยท extended-hours price shown1hโ
24hโฒ 0.3%
7dโฒ 3.3%
14dโฒ 10.1%
30dโฒ 14.2%
1yโฒ 159.3%
๐ฆMarket Cap
$2.69B
Small Cap
๐Revenue Growth (YoY)
-58.4%
Declining
๐Gross Margin
โ
๐ตFCF Margin
65.6%
Strong
โ๏ธP/S Ratio
73.1x
Expensive
Otter Score
64
Fair
Earnings
Q2 ยท 2026Reported 2026-06-30Earnings Per Share
Actual
-0.81
Expected
-0.73
miss
โ10.80%
Revenue
Actual
โ
Expected
โ
โ
โ
Consensus estimates
Recent quarters
Q2 2026
-0.81
miss
Q1 2026
-0.79
miss
Q4 2025
-0.82
beat
Q3 2025
-1.03
miss